← SynDRA
ABT-751
SynDRA canonical compound SYN0001177 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | TUBB |
|---|
| Mechanism of action | tubulin polymerization inhibitor |
|---|
All known targets
- TUBB
- TUBB1
- TUBB2A
- TUBB2B
- TUBB3
- TUBB4A
- TUBB4B
- TUBB6
- TUBB8
- TUBB8B
Mechanisms of action (all sources)
- TUBB4B INHIBITOR
- Tubulin beta inhibitor
- TUBB1 INHIBITOR
- TUBB3 INHIBITOR
- TUBB4A INHIBITOR
- TUBB8 INHIBITOR
- TUBB INHIBITOR
- TUBB2A INHIBITOR
- TUBB2B INHIBITOR
- TUBB6 INHIBITOR
- TUBB8B INHIBITOR
- tubulin polymerization inhibitor
Cross-references
Synonyms
- E-7010
- NSC-742134
- ABT 751
- E 7010
- ABT751
- ABT-751 (E7010)
- UNII-WDT5V5OB9F
- WDT5V5OB9F
- N-[2-[(4-HYDROXYPHENYL)AMINO]-3-PYRIDYL]-4-METHOXYBENZENESULFONAMIDE
- CHEMBL20684
- N-(2-((4-Hydroxyphenyl)amino)-3-pyridinyl)-4-methoxybenzenesulfonamide
- N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzenesulfonamide
- Benzenesulfonamide,N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxy-
- N-(2-(4-hydroxyphenylamino)pyridin-3-yl)-4-methoxybenzenesulfonamide
- E7010
- NSC 742134
- RefChem:108577
- DTXCID90817806
- Colchicine-Site Binding Agent ABT-751
- MFCD00910291
- MLS006011263
- SCHEMBL111645
- orb1307520
- SCHEMBL5111661
- SCHEMBL5111667
- SCHEMBL29355261
- CHEBI:95043
- EX-A517
- URCVCIZFVQDVPM-UHFFFAOYSA-N
- E 7010 [WHO-DD]
- GLXC-04546
- HMS3654C14
- HMS3672M11
- RFA43065
- BDBM50101086
- NSC742134
- s1165
- AKOS024457996
Look up ABT-751 in the interactive SynDRA portal →